Deep search
Search
Images
Copilot
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Procter & Gamble Stock Jumps on Sales and Earnings Beat
Procter & Gamble stock rose in premarket trading Tuesday after the consumer-staples company reported fiscal second-quarter sales and earnings that surpassed Wall Street expectations. Shares of Procter & Gamble were up 3% to $166.
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share.
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical technology and drug company beat estimates for the fourth quarter, but offered some mixed guidance.
Procter & Gamble Stock Rises on Earnings Beat: What to Know
Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its fiscal 2025 second quarter.
How To Earn $500 A Month From GE Aerospace Stock Ahead Of Q4 Earnings
GE Aerospace (NYSE:GE) will release its fourth-quarter financial results before the opening bell on Thursday, Jan. 23. Analysts expect the Ohio-based company to report quarterly earnings at $1.04 per share,
Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines to go off patent in the coming weeks.
J&J Skids After Dow Giant Beat Earnings Views, But 'Prudent' Guidance Disappoints
Johnson & Johnson stock gapped down Wednesday after the health care giant issued light 2025 sales guidance, taking a hit from exchange rates.
1h
Johnson & Johnson Dips On Q4 Earnings: Here's What The Market Isn't Seeing
Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...
4h
Tesla Gears Up to Report Q4 Earnings: Here's What to Expect
The Zacks Consensus Estimate for TSLA's fourth-quarter earnings and revenues is pegged at 76 cents per share and $27.61 ...
Hosted on MSN
54m
Comerica Q4 Earnings Miss Estimates on Lower NII, Fee Income Rises Y/Y
Comerica Incorporated CMA reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.2, missing the Zacks Consensus ...
1h
Is Netflix Stock Still a Buy After Earnings, Price Hikes?
Analysts were bullish on Netflix stock ahead of its earnings beat, but what is Wall Street saying now? We take a closer look.
20h
on MSN
Netflix Earnings Soar, Subscribers Hit 302 Million
Netflix demonstrated strong financial performance in its latest earnings release, surpassing analyst expectations and setting ...
13h
SBC-Fueled Cash Flows And Weak Growth Make Snap A Sell Into Earnings
Snap's valuation appears egregious, with EV/EBITDA indicating it's the most expensive among peers. See here to know why we ...
21h
Seagate: Fiscal Q2 Earnings Snapshot
SINGAPORE — SINGAPORE — Seagate Technology Holdings plc (STX) on Tuesday reported fiscal second-quarter earnings of $336 million. On a per-share basis, the Singapore-based company said it had net ...
1h
on MSN
Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings.
Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Johnson & Johnson
Procter & Gamble
Peoples Bancorp
EPS
Feedback